placebo (mean change from baseline 14.9% vs
Board-certified obesity and anti-aging specialists On-site phlebotomy, DEXA, and ultrasound to track visceral-fat changes Compounded peptides from FDA-registered 503B pharmacies Integrated programs that layer GLP-1, body-contouring, and nutrition coaching for synergistic outcomes 10
Note that these are practitioner protocols, not FDA-approved dosing guidelines
Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT
Long-term monitoring: We see patients at 1, 3, 6, and 12 months post-GLP-1
the Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Gainesville (K.C.)